Non-invasive liver fibrosis markers, FIB-4, PRO-C3 and ADAPT, are significantly elevated in biopsy confirmed NAFLD patients at high risk of developing coronary heart disease and cardiovascular disease and are promising clinical decision making tools

被引：0

作者：

Daniels, Samuel ^{[1
]}

Nielsen, Mette ^{[1
]}

Eslam, Mohammed ^{[2
,3
]}

Karsdal, Morten ^{[1
]}

Adams, Leon ^{[4
]}

George, Jacob ^{[2
,3
]}

机构：

[1] Nord Biosci Biomarkers & Res, Fibrosis Res, Herlev, Denmark

[2] Univ Sydney, Westmead Inst Med Res, Westmead, NSW, Australia

[3] Westmead Hosp, Storr Liver Ctr, Westmead, NSW, Australia

[4] Univ Western Australia, Sch Med, Nedlands, WA, Australia

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI071

引用

页码：S435 / S435

页数：1